Rydén Lisa, Boiesen Poul, Jönsson Per-Ebbe
Department of Surgery, Helsingborg Hospital, Helsingborg, Sweden.
Anticancer Res. 2004 Jan-Feb;24(1):371-5.
Estimation of microvessel density (MVD) in primary breast cancer in core needle biopsies (CNB) may predict response to systemic therapy. The aim of the present study was to explore the accuracy of assessment of MVD in CNB related to MVD in excised tumours.
MVD was estimated in core biopsies and subsequently excised tumours in 54 consecutive patients with breast cancer without pre-operative treatment.
The correlation between MVD in CNB and excised tumours was non-significant. However, in tumours larger than 20 mm (r=0.56, p=0.005) and in lobular carcinomas (r=0.55, p=0.014) a significant correlation was observed.
The overall accuracy between estimation of MVD on CNB and excised breast tumours was non-significant. The usefulness of MVD in CNB as a marker of response to systemic therapy should be further validated before it can be used in clinical practice.
在粗针活检(CNB)中评估原发性乳腺癌的微血管密度(MVD)可能预测对全身治疗的反应。本研究的目的是探讨CNB中MVD评估与切除肿瘤中MVD评估的准确性。
对54例未经术前治疗的连续乳腺癌患者进行粗针活检并随后切除肿瘤,评估其中的MVD。
CNB中的MVD与切除肿瘤中的MVD之间的相关性无统计学意义。然而,在大于20mm的肿瘤中(r=0.56,p=0.005)以及小叶癌中(r=0.55,p=0.014)观察到显著相关性。
CNB中MVD评估与切除的乳腺肿瘤之间的总体准确性无统计学意义。在CNB中,MVD作为全身治疗反应标志物的实用性在用于临床实践之前应进一步验证。